1Mogensen CE. Management of early nephropathy in diabetic patients[J ]. Annu Rev Med 1995 ; (46) :79.
2Pistrosch F, Herbrig K Kindel B, et al. Rosiglitazone improves glomeular hyper filtration, renal endothelial dysfunction, and microalbuminutia of incipient diabetic nephropathy in patients[J]. Diabetes 2005; 54:2206 - 2211.
3Arima S, Kohagura K, Takeuchi K, et al. Biphasic vasodilator action of troglitazone on the renal microcirculation [J ]. J Am Soc Nephrol 2002 ; 13 : 342 - 349.
4Lacourciere Y, Belanger A, Godin C, et al. Long-term comparison of Losartan and Enalaprll on kidney function in hypertensive type 2 diabetics with early nephropathy[J]. Kidney Int 2000;58(2):762.
5Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of Losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy[J]. N Engl J Med 2001;345(12) :861.
